Tag Archives: First

FDA OKs Trifarotene, First New Retinol Acne Cream in 20 Years – Medscape

The US Food and Drug Administration (FDA) has approved trifarotene cream 0.005% (Aklief, Galderma), the first new retinoid molecule to be approved in the United States in over 20 years for the once-daily topical treatment of acne vulgaris, according to a company news release. Trifarotene is the only topical retinoid that selectively targets retinoic acid… Read More »

FDA Approves Rybelsus (semaglutide), the First Oral GLP-1 Analog Treatment for Adults with Type 2 Diabetes

FDA Approves Rybelsus (semaglutide), the First Oral GLP-1 Analog Treatment for Adults with Type 2 Diabetes Print this page PLAINSBORO, N.J., Sept. 20, 2019 /PRNewswire/ — Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus (semaglutide) tablets 7 mg or 14 mg for adults with type 2 diabetes that… Read More »

FDA Approves Gvoke (glucagon), the First Ready-to-use Stable Liquid Glucagon for Severe Hypoglycemia

FDA Approves Gvoke (glucagon), the First Ready-to-use Stable Liquid Glucagon for Severe Hypoglycemia Print this page CHICAGO–(BUSINESS WIRE)–Sep. 10, 2019– Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that it has received regulatory approval from the U.S.… Read More »

First Death Tied to Lung Injury From Vaping Reported in Illinois

FRIDAY, Aug. 23, 2019 — An Illinois resident who was hospitalized after suffering severe respiratory illness related to vaping has died, state health officials reported Friday. In addition, the number of reported cases of people who have used e-cigarettes or vaped and have been hospitalized with respiratory symptoms has doubled in Illinois this past week,… Read More »

Nabriva scores its first FDA nod with novel antibiotic Xenleta

With drug-resistant bacteria on the rise, antibiotics have struggled to keep up with the challenge. Now, with the FDA’s approval of a new antibiotic for bacterial pneumonia, some of that may change.  Monday, the FDA approved Nabriva Therapeutics’ Xenleta (lefamulin) to treat community-acquired bacterial-pneumonia (CABP) as the first in a new class of antibiotics called pleuromutilins, which… Read More »